Rocket Lab (NASDAQ:RKLB) Director Merline Saintil Sells 96,000 Shares of Stock

Rocket Lab Corporation (NASDAQ:RKLB) Director Merline Saintil sold 96,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $86.58, for a total value of $8,311,680.00. Following the sale, the director owned 292,529 shares in the company, valued at approximately $25,327,160.82. This trade represents a 24.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Merline Saintil also recently made the following trade(s):

• On Wednesday, January 14th, Merline Saintil sold 12,500 shares of Rocket Lab stock. The stock was sold at an average price of $90.00, for a total value of $1,125,000.00.
• On Friday, December 19th, Merline Saintil sold 5,000 shares of Rocket Lab stock. The shares were sold at an average price of $65.00, for a total value of $325,000.00.
• On Wednesday, December 17th, Merline Saintil sold 5,000 shares of Rocket Lab stock. The shares were sold at an average price of $54.46, for a total value of $272,300.00.
• On Friday, December 12th, Merline Saintil sold 15,000 shares of Rocket Lab stock. The stock was sold at an average price of $65.00, for a total value of $975,000.00.
• On Thursday, December 4th, Merline Saintil sold 10,000 shares of Rocket Lab stock. The stock was sold at an average price of $48.00, for a total transaction of $480,000.00.

Rocket Lab Trading Down 1.1%

Shares of RKLB opened at $90.76 on Friday. The company’s fifty day simple moving average is $60.64 and its 200-day simple moving average is $53.67. The company has a market cap of $48.48 billion, a P/E ratio of -238.84 and a beta of 2.16. The company has a current ratio of 3.18, a quick ratio of 2.83 and a debt-to-equity ratio of 0.32. Rocket Lab Corporation has a twelve month low of $14.71 and a twelve month high of $92.46.

Rocket Lab (NASDAQ:RKLB) last released its quarterly earnings results on Monday, November 10th. The rocket manufacturer reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.02. Rocket Lab had a negative net margin of 35.64% and a negative return on equity of 27.26%. The firm had revenue of $155.08 million during the quarter, compared to analysts’ expectations of $152.45 million. During the same period in the previous year, the company earned ($0.10) EPS. The firm’s revenue for the quarter was up 48.0% compared to the same quarter last year. As a group, analysts expect that Rocket Lab Corporation will post -0.38 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Lodestone Wealth Management LLC purchased a new stake in shares of Rocket Lab in the 4th quarter worth approximately $195,000. Cherry Creek Investment Advisors Inc. raised its stake in Rocket Lab by 50.9% in the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 11,318 shares of the rocket manufacturer’s stock worth $790,000 after buying an additional 3,817 shares in the last quarter. Nikulski Financial Inc. purchased a new stake in Rocket Lab during the fourth quarter worth $575,000. Fifth Third Wealth Advisors LLC purchased a new stake in Rocket Lab during the fourth quarter worth $249,000. Finally, Silver Oak Securities Incorporated boosted its position in Rocket Lab by 26.7% during the 4th quarter. Silver Oak Securities Incorporated now owns 3,828 shares of the rocket manufacturer’s stock valued at $270,000 after acquiring an additional 807 shares in the last quarter. Hedge funds and other institutional investors own 71.78% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on RKLB. Weiss Ratings restated a “sell (d-)” rating on shares of Rocket Lab in a report on Wednesday, October 8th. Robert W. Baird started coverage on shares of Rocket Lab in a research note on Wednesday, October 15th. They set an “outperform” rating and a $83.00 target price for the company. Zacks Research raised shares of Rocket Lab from a “hold” rating to a “strong-buy” rating in a research note on Monday. Morgan Stanley set a $105.00 price objective on shares of Rocket Lab and gave the company an “overweight” rating in a research report on Friday. Finally, Stifel Nicolaus raised their target price on shares of Rocket Lab from $75.00 to $85.00 and gave the stock a “buy” rating in a research report on Monday, December 22nd. Three equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $64.42.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Large defense contract and backlog expansion that underpins growth expectations (boosts revenue/backlog visibility). Defense Contract Win Drives Shares to All-Time High
• Positive Sentiment: Analysts and deep-dive pieces argue Rocket Lab is moving into a higher-revenue tier (~$900M revenue forecast for 2026) as Defense & Space Systems backlog converts and Electron/Neutron programs scale. This supports sustained high growth expectations. Rocket Lab Enters A Different League
• Positive Sentiment: Some brokerages remain bullish (Cantor Fitzgerald cited as bullish alternative to SpaceX; Zacks recently upgraded to a “strong-buy”), which keeps buy-side interest alive despite short-term pullbacks. Rocket Lab: Premier Alternative To SpaceX in 2026
• Neutral Sentiment: Technical and market-flow coverage (momentum indicators, options “whales,” small-cap rotation) has amplified volatility — these items can cause outsized intraday moves but don’t change fundamentals. Check Out What Whales Are Doing With RKLB
• Negative Sentiment: KeyBanc downgraded RKLB from Overweight to Sector Weight, citing valuation and that recent “Neutron euphoria” may have pushed the stock into overbought territory. That downgrade triggered profit-taking and pressured the share price. KeyBanc downgrades Rocket Lab (RKLB)
• Negative Sentiment: Insider selling by director Merline Saintil — large filings show substantial share disposals on consecutive days (96,000 and 12,500 shares) — which can signal near-term dilution/lockup monetization or prompt investor caution. SEC Filing – Insider Sales
• Negative Sentiment: Critical takes warning that the rally may be overextended and susceptible to a sizable pullback if execution or Neutron timelines slip. Neutron Euphoria Has Pushed RKLB Into Sell Territory

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.